The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer (2020)

First Author: McCuaig, Sarah

Attributed to: Pathfinder: Defining interactions between the cytokine IL-22 and oncogenic KRAS as a new therapeutic target in colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.5167/uzh-207864

Publication URI: https://www.zora.uzh.ch/id/eprint/207864

Type: Other